Tech Company Financing Transactions

Annexon Biosciences Funding Round

On 12/16/2014, Annexon Biosciences announced $34 million in Series A financing from Novartis Venture Fund, Clarus and Satter Investment Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

180 Kimball Way 2nd Floor 200
San Francisco, CA 94080
USA

Phone

(650) 822-5500

Website

www.annexonbio.com

Email Address

[email protected]

Overview

Annexon is a California-based healthcare company engaged in the R&D of novel disease-modifying drugs for neurodegenerative disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Douglas Love

        

Chief Financial Officer

Jennifer Lew

        

Chief Medical Officer

Sanjay Keswani

        

Chief Scientific Officer

Ted Yednock

        

Browse more venture capital transactions:

Prev: 12/16/2014: Clever venture capital transaction
Next: 12/16/2014: Blue Triangle venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary